Marinus Pharmaceuticals Inc
NASDAQ:MRNS

Watchlist Manager
Marinus Pharmaceuticals Inc Logo
Marinus Pharmaceuticals Inc
NASDAQ:MRNS
Watchlist
Price: 1.33 USD 2.31% Market Closed
Updated: May 19, 2024
MRNS
/
Income Statement
/
Cost of Revenue

Marinus Pharmaceuticals Inc
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Marinus Pharmaceuticals Inc
Cost of Revenue Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Marinus Pharmaceuticals Inc
NASDAQ:MRNS
Cost of Revenue
-$2.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Johnson & Johnson
NYSE:JNJ
Cost of Revenue
-$26.1B
CAGR 3-Years
3%
CAGR 5-Years
1%
CAGR 10-Years
-2%
Bristol-Myers Squibb Co
NYSE:BMY
Cost of Revenue
-$11B
CAGR 3-Years
-3%
CAGR 5-Years
-10%
CAGR 10-Years
-9%
Pfizer Inc
NYSE:PFE
Cost of Revenue
-$16.3B
CAGR 3-Years
-57%
CAGR 5-Years
N/A
CAGR 10-Years
-6%
Merck & Co Inc
NYSE:MRK
Cost of Revenue
-$15.4B
CAGR 3-Years
-5%
CAGR 5-Years
-4%
CAGR 10-Years
1%
Eli Lilly and Co
NYSE:LLY
Cost of Revenue
-$7.1B
CAGR 3-Years
-5%
CAGR 5-Years
-9%
CAGR 10-Years
-4%

See Also

What is Marinus Pharmaceuticals Inc's Cost of Revenue?
Cost of Revenue
-2.5m USD

Based on the financial report for Mar 31, 2024, Marinus Pharmaceuticals Inc's Cost of Revenue amounts to -2.5m USD.

What is Marinus Pharmaceuticals Inc's Cost of Revenue growth rate?
Cost of Revenue CAGR 1Y
-353%

Over the last year, the Cost of Revenue growth was -353%.

ALPHA SPREAD
Join more than 138,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.